Named on one round in the feed.
Since 2023-03-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Flare Therapeutics A biotech startup targeting transcription factors | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |